Tianshui Zhongxing Bio-technology Co (002772.SZ) Osake Kurssi

Tianshui Zhongxing Bio-Technology Co., Ltd. generates revenue through the research, development, and manufacturing of edible and medical mushrooms. The company sells enoki mushroom, king oyster mushroom, and beech mushroom as its primary edible mushroom products. Through its subsidiaries, it also produces and sells medicinal mushroom, auxiliary materials, and agricultural by-products. The firm focuses on microbial technology, biological engineering, and new agricultural technologies for application and promotion. Its customer segments include consumers seeking edible and medicinal mushroom products, as well as businesses requiring agricultural technology solutions. The company's product portfolio includes edible mushrooms like enoki, king oyster, and beech varieties, alongside medicinal mushrooms and auxiliary materials. Subsidiaries handle production and distribution of these items, leveraging microbial and biological engineering technologies. The business targets both retail consumers and B2B clients in the agricultural and health sectors. Revenue streams are derived from direct sales of mushroom products and technology applications. Tianshui Zhongxing's operations are centered around edible and medical mushroom production, with subsidiaries expanding into agricultural by-products and technology services. The firm's revenue comes from selling enoki, king oyster, and beech mushrooms, medicinal mushrooms, and auxiliary materials. It serves markets requiring mushroom-based health products and agricultural technology innovations, with no mention of external partnerships or additional revenue sources.